Literature DB >> 4893737

The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine.

A O Lucas, R G Hendrickse, O A Okubadejo, W H Richards, R A Neal, B A Kofie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4893737     DOI: 10.1016/0035-9203(69)90150-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  15 in total

Review 1.  Malaria. Chemoprophylaxis and chemotherapy.

Authors:  W Peters
Journal:  Br Med J       Date:  1971-04-10

2.  The battle for survival: a look at child health in Nigeria.

Authors:  R G Hendrickse
Journal:  Ir J Med Sci       Date:  1971-10       Impact factor: 1.568

3.  Prolonged malaria prophylaxis.

Authors:  L J Bruce-Chwatt
Journal:  Br Med J       Date:  1977-11-12

4.  Erythema multiforme (Stevens-Johnson) precipitated by Fansidar.

Authors:  S J Adams; J Broadbent; L M Clayden; C M Ridley
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

5.  Chemoprophylaxis of malaria.

Authors: 
Journal:  Br Med J       Date:  1976-11-20

6.  Agranulocytosis associated with Maloprim.

Authors:  L J Bruce-Chwatt; D B Hutchinson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-07

7.  The impact of malaria chemoprophylaxis in Africa with special reference to Madagascar, Cameroon, and Senegal.

Authors:  A B Laing
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

Review 8.  The treatment of malaria.

Authors:  A P Hall
Journal:  Br Med J       Date:  1976-02-07

9.  Malaria suppression with fortnightly doses of pyrimethamine with sulfadoxine in the Gambia.

Authors:  A B Laing
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

10.  Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers.

Authors:  Darren R Krause; Michelle L Gatton; Sarah Frankland; Damon P Eisen; Michael F Good; Leann Tilley; Qin Cheng
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.